Phost’in Therapeutics joins TechShare 2022, Euronext’s paneuropean Pre-IPO training program
Montpellier, France – Mars 2022, 09th
Phost’in Therapeutics strengthens management with appointment of veteran lifescience executives Dr. Alain Herrera and Pr. Bernard Pau
Montpellier, France – June 2020, 17th
Phost’in Therapeutics raises €10.3m to develop First-in-Class N-glycosylation Inhibitors for Cancer Treatment
Montpellier, France – April 2020, 20th